K-V Pharmaceutical Co. KVPBQ Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
K-V Pharmaceutical Co. KVPBQ Company Overview 

Stock Message Board http://investorshangout.com/search?q=KVPBQ&am...mp;yt1=Go!

K-V Pharmaceutical Co. KVPBQ Current Price and Quotes
Last Price 0.078
Previous Close 0.088 Open 0.078
Daily Range 0.078 - 0.078 52wk Range 0.86 - 0.025
Volume 5,200 Dividend N/A
Average Vol (3m) 20,382 Yield N/A
K-V Pharmaceutical Co. KVPBQ
Company Information

16640 Chesterfield Grove Rd.
Suite 200
Chesterfield, MO 63005

Website: http://www.kvph.com
Phone: 314-645-6600

K-V Pharmaceutical Co. KVPBQ
K-V Pharmaceutical Co. KVPBQ
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Mar 31, 2012 10-K
CIK 0000057055
Fiscal Year End 3/31
OTC Marketplace OTC Pink Limited
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Bankrupt
Incorporated In: DE, USA
Year of Inc. 1971
Employees Not Available
Company Officers/Contacts

Gregory Divis President, CEO
Thomas McHugh CFO
Patrick Christmas General Counsel, Secretary
Debbie Lanemann Legal Asst.
Company Directors

Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

K-V Pharmaceutical Co. KVPBQ
KVPBQ Security Details Other Company Securities

Share Structure

Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value  2.05
Shareholders

Shareholders of Record 649 a/o Jun 14, 2012
Security Notes

New Issue=9-71 210,000 shs at $15 1/2 by Reinholdt & Gardner et al.
Par Changed=3-83 50 cents to 25 cents Basis: 2 for 1 split
Latest Addt'l & Secondary Issue=9-83 675,000 shs at $8.50 by Bateman Eichler, Hill Richards, Inc
Capital Change=7-86 shs increased by 3 for 2 split
Reclassified=6-87 Com as Class B Com Basis: sh for sh
Capital Change=Capital Change=shs increased by 3 for 2 split. . Ex-date=09/08/2000. Rec date=08/28/2000. Pay date=09/07/2000.
Short Selling Data

Short Interest 0 (-100%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



K-V Pharmaceutical Co. KVPBQ Recent News

Aug 5, 2013 Ther-Rx Corporation Announces the Availability of Clindesse® (Clindamycin Phosphate) Vaginal Cream, 2% for Prescribing


K-V Pharmaceutical Co. KVPBQ Financials
Period Ending Mar 31, 2012 Mar 31, 2011 Mar 31, 2010 Mar 31, 2009
Total Revenue 23,200 27,300 9,100 113,200
Cost of Revenue 2,300 1,100 1,600 15,100
Gross Profit 20,900 26,200 7,500 98,100
Operating Expenses

Research and Development 16,100 19,100 27,100 69,800
Sales, General and Admin. 114,300 101,100 111,700 220,700
Non-Recurring Items 31,700 7,500 174,000 98,400
Other - - - -
Operating Income (141,200) (101,500) (305,300) (290,800)
Income From Continuing Operations

Add'l Income/Expense Items 92,400 (130,900) 5,800 (6,300)
Earnings Before Interest and Tax (48,800) (232,400) (299,500) (297,100)
Interest Expense 39,200 15,700 8,000 9,300
Earnings Before Tax (88,000) (248,100) (307,500) (306,400)
Income Tax 10,000 7,800 (23,900) (38,600)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (98,000) (255,900) (283,600) (267,800)
Non Recurring Events

Discontinued Operations (4,300) (15,800) - (45,800)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (102,300) (271,700) (283,600) (313,600)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (102,300) (271,700) (283,600) (313,600)

KVPBQ K-V Pharmaceutical Co. Research DD Guide

KVPBQ K-V Pharmaceutical Co. Stock Message Board http://investorshangout.com/search?q=KVPBQ&am...mp;yt0=Go!
KVPBQ K-V Pharmaceutical Co. Stock Quote http://www.otcmarkets.com/stock/KVPBQ/quote
KVPBQ K-V Pharmaceutical Co. Stock Chart http://www.otcmarkets.com/stock/KVPBQ/chart
KVPBQ K-V Pharmaceutical Co. Company Info http://www.otcmarkets.com/stock/KVPBQ/company-info
KVPBQ K-V Pharmaceutical Co. Recent News http://www.otcmarkets.com/stock/KVPBQ/news
KVPBQ K-V Pharmaceutical Co. Financials http://www.otcmarkets.com/stock/KVPBQ/financials
KVPBQ K-V Pharmaceutical Co. Filings and Disclosure http://www.otcmarkets.com/stock/KVPBQ/filings
KVPBQ K-V Pharmaceutical Co. Short Sales http://www.otcmarkets.com/stock/KVPBQ/short-sales
KVPBQ K-V Pharmaceutical Co. Insider Disclosure http://www.otcmarkets.com/stock/KVPBQ/insider-transactions
KVPBQ K-V Pharmaceutical Co. Research Reports http://www.otcmarkets.com/stock/KVPBQ/research
KVPBQ K-V Pharmaceutical Co. Summary http://finance.yahoo.com/q?s=KVPBQ
KVPBQ K-V Pharmaceutical Co. Historical Prices http://finance.yahoo.com/q/hp?s=KVPBQ+Historical+Prices
KVPBQ K-V Pharmaceutical Co. Interactive Chart http://finance.yahoo.com/echarts?s=KVPBQ
KVPBQ K-V Pharmaceutical Co. Basic Chart http://finance.yahoo.com/q/bc?s=KVPBQ+Basic+Chart
KVPBQ K-V Pharmaceutical Co. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=KVPBQ+Basic+Tech.+Analysis
KVPBQ K-V Pharmaceutical Co. Headlines http://finance.yahoo.com/q/h?s=KVPBQ+Headlines
KVPBQ K-V Pharmaceutical Co. Press Releases http://finance.yahoo.com/q/p?s=KVPBQ+Press+Releases
KVPBQ K-V Pharmaceutical Co. Company Profile http://finance.yahoo.com/q/pr?s=KVPBQ+Profile
KVPBQ K-V Pharmaceutical Co. Key Statistics http://finance.yahoo.com/q/ks?s=KVPBQ+Key+Statistics
KVPBQ K-V Pharmaceutical Co. Industry http://finance.yahoo.com/q/in?s=KVPBQ+Industry
KVPBQ K-V Pharmaceutical Co. Major Holders http://finance.yahoo.com/q/mh?s=KVPBQ+Major+Holders
KVPBQ K-V Pharmaceutical Co. Insider Transactions http://finance.yahoo.com/q/it?s=KVPBQ+Insider+Transactions
KVPBQ K-V Pharmaceutical Co. Insider Roster http://finance.yahoo.com/q/ir?s=KVPBQ+Insider+Roster
KVPBQ K-V Pharmaceutical Co. Income Statement http://finance.yahoo.com/q/is?s=KVPBQ
KVPBQ K-V Pharmaceutical Co. Balance Sheet http://finance.yahoo.com/q/bs?s=KVPBQ
KVPBQ K-V Pharmaceutical Co. Cash Flow http://finance.yahoo.com/q/cf?s=KVPBQ+Cash+Flow&annual
KVPBQ K-V Pharmaceutical Co. Nasdaq http://www.nasdaq.com/symbol/KVPBQ
KVPBQ K-V Pharmaceutical Co. Market Watch http://www.marketwatch.com/investing/stock/KVPBQ
KVPBQ K-V Pharmaceutical Co. Bloomberg http://www.bloomberg.com/quote/KVPBQ:US
KVPBQ K-V Pharmaceutical Co. Morningstar http://quotes.morningstar.com/stock/s?t=KVPBQ
KVPBQ K-V Pharmaceutical Co. Bussinessweek http://investing.businessweek.com/research/st...cker=KVPBQ
KVPBQ K-V Pharmaceutical Co. Barchart http://www.barchart.com/quotes/stocks/KVPBQ
KVPBQ K-V Pharmaceutical Co. OTC Short Report http://otcshortreport.com/index.php?index=KVPBQ
KVPBQ K-V Pharmaceutical Co. Investopedia http://www.investopedia.com/markets/stocks/KVPBQ/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NABEP's Strategic Push: 41 Rigs to Bolster Output

Updated Category News Views 174

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

Continue Reading
Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 65

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
Duolingo Investors Must Weigh Legal Options Now

Updated Category News Views 120

Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...

Continue Reading
HK Boosts Oversight of Building Repairs Post-Blaze

Updated Category News Views 125

Big Moves After a Tragic Fire Hong Kong's revamping its approach to building maintenance and oversight, clearly in reaction to the horrific Wang Fuk Court blaze last year. That fire didn't just leave scars; it blew open glaring gaps in the city's oversight of building repairs. The government's now jumping into action by launching a raft of measures aimed at preventing...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 152

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
Millrose Properties Faces Legal Storm: Investors Alerted

Updated Category News Views 176

Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...

Continue Reading
Alignment Healthcare Faces Investigation Over Alleged Fraud

Updated Category News Views 76

Rough Waters at Alignment Healthcare Not every day we hear about a company sinking its own ship over bookkeeping shenanigans, but here we are. Alignment Healthcare, sitting on Nasdaq under ticker ALHC, is facing the kind of scrutiny that sends shivers down a boardroom's spine. Yeah, Kahn Swick & Foti—those big hitters in securities litigation—have launched an...

Continue Reading
Race for Life Rescue Logs 200 Flights for Shelter Pets

Updated Category News Views 96

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Continue Reading
Chemours Class Action: Key Deadline Approaches Fast

Updated Category News Views 77

A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...

Continue Reading
Langford Chosen for Navy Mutual's 2026 Bolles Award

Updated Category News Views 155

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...

Continue Reading

Top 5 Most Recently Viewed Articles

Stephen Merkel Takes Charge as Chairman of Newmark's Board

Updated Category News Views 330

Stephen Merkel Takes Over as Chairman of Newmark's Board In an impactful leadership transition, Stephen Merkel has been appointed as the new Chairman of the Board of Directors at Newmark Group, Inc. (NASDAQ: NMRK). This significant change comes as Howard W. Lutnick steps down from his role as Executive Chairman to assume responsibilities as the 41st Secretary of Commerce....

Continue Reading
Medtronic's Upcoming Financial Results and Company Innovations

Updated Category News Views 180

Medtronic to Report First Quarter Financial Results Medtronic plc (NYSE: MDT), a prominent leader in healthcare technology, is set to announce its financial outcomes for the first quarter of fiscal year 2026. The results will encapsulate a crucial period of growth and innovation as the company continues to transform healthcare solutions. The report will be released soon,...

Continue Reading
Celebrating a Legacy: Dr. David Olansky's Retirement Journey

Updated Category News Views 168

Dr. David Olansky's Impressive Career in Dermatology After more than four decades of dedicated service in dermatology, Dr. David Olansky, co-founder of Olansky Dermatology & Aesthetics, is retiring. This esteemed practice, known as Georgia's premier dermatology clinic, has been supported by Dr. Olansky's expertise and vision since its establishment in 1981. From...

Continue Reading
SureMark Digital Unveils Comprehensive Identity Protection Suite

Updated Category News Views 275

SureMark Digital Launches Innovative Identity Protection Suite SureMark Digital has made an exciting advancement in the world of wealth management with the introduction of an identity protection suite. Founded by blockchain visionaries Drs. W. Scott Stornetta and Stuart Haber, the company focuses on providing robust solutions to safeguard both private bankers and their...

Continue Reading
Options Activity Signals Insight for First Majestic Silver

Updated Category News Views 208

Strategic Insights on First Majestic Silver's Options Activity Recent trading trends indicate that significant financial players are making noticeable bearish moves on First Majestic Silver (NYSE: AG). Our analysis highlights 20 unusual trades related to this stock, revealing market sentiment and future expectations. Understanding the Current Market Sentiment Diving...

Continue Reading